Organization · Venture Capital
HTH
HTH (Health Technology Holding) is a Milan-based venture capital firm that invests in early to mid-stage life sciences companies with breakthrough technologies. It operates internationally, focusing on sectors such as medtech, biotech, and digital health.
Overview
What HTH does
What HTH is
HTH (Health Technology Holding) is a Milan-based venture capital firm that invests in early to mid-stage life sciences companies with breakthrough technologies. It operates internationally, focusing on sectors such as medtech, biotech, and digital health.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2020
- Approximate age
- About 6 years
- Structured capabilities
- Funder
- Last reviewed
- March 31, 2026
Official channels
Find HTH elsewhere
Open the official website or a supported primary organization account.
Capability profile
HTH as a funder
Investment thesis
HTH focuses on breakthrough life sciences technologies, providing hands-on capital to early to mid-stage companies.
Focus narrative
HTH invests internationally across various sectors within life sciences, including medtech, biotech, digital health, femtech, diagnostics, and consumer healthcare. The firm aims to provide not just capital but also strategic support to help companies navigate the complexities of the healthcare landscape.
Value beyond capital
HTH adds value to its portfolio companies by leveraging the extensive networks and expertise of the Zambon Group, providing insights into regulatory processes and pathways to commercialization.
Focus and fit
- Sectors
- Biotech · Digital Health · Femtech · Diagnostics
- Regions
- Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 2
Portfolio context
SOM Biotech — AI-powered drug repurposing. Neurofenix — Neurological rehabilitation platform using sensor technology.
Common questions
What to know about HTH
Upseed classifies HTH under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 31, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.